Identification of NIFTP-Specific MRNA Markers for Reliable Molecular Diagnosis of Thyroid Tumors

Overview

Journal Endocr Pathol

Specialties Endocrinology
Pathology

Date 2023 Sep 2

PMID 37658903

Authors

So-Yeon Lee

Jong-Lyul Park

Kwangsoon Kim

Ja Seong Bae

Jae-Yoon Kim

Seon-Young Kim

Chan Kwon Jung

Affiliations

Soon will be listed here.

Abstract

Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) is a low-risk thyroid tumor with a favorable prognosis. Nonetheless, differentiating NIFTP from other thyroid tumors remains challenging, necessitating reliable diagnostic markers. This study is aimed at discovering NIFTP-specific mRNA markers through RNA sequencing analysis of thyroid tumor tissues. We performed mRNA expression profiling for 74 fresh frozen thyroid tissue samples, including NIFTP and benign and malignant follicular-cell-derived tumors. NIFTP/malignant tumors showed 255 downregulated genes and 737 upregulated genes compared to benign tumors. Venn diagram analysis revealed 19 significantly upregulated and 7 downregulated mRNAs in NIFTP. Akaike information criterion analysis allowed us to select OCLN, ZNF423, LYG1, and AQP5 mRNA markers. We subsequently developed a predictive model based on logistic regression analysis using these four mRNAs, which we validated in independent samples (n = 90) using a qRT-PCR assay. This model demonstrated high accuracy in predicting NIFTP in discovery dataset (AUC (area under the receiver operating characteristic) = 0.960) and the validation dataset (AUC = 0.757). Our results suggest that OCLN, ZNF423, LYG1, and AQP5 mRNA markers might serve as reliable molecular markers for identifying NIFTP among other thyroid tumors, ultimately aiding in accurate diagnosis and management of NIFTP patients.

References

Baloch Z, Asa S, Barletta J, Ghossein R, Juhlin C, Jung C . Overview of the 2022 WHO Classification of Thyroid Neoplasms. Endocr Pathol. 2022; 33(1):27-63. DOI: 10.1007/s12022-022-09707-3. View

Jung C, Bychkov A, Kakudo K . Update from the 2022 World Health Organization Classification of Thyroid Tumors: A Standardized Diagnostic Approach. Endocrinol Metab (Seoul). 2022; 37(5):703-718. PMC: 9633223. DOI: 10.3803/EnM.2022.1553. View

Nikiforov Y, Seethala R, Tallini G, Baloch Z, Basolo F, Thompson L . Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors. JAMA Oncol. 2016; 2(8):1023-9. PMC: 5539411. DOI: 10.1001/jamaoncol.2016.0386. View

Katsakhyan L, Song S, Lepe M, Shojaei H, Montone K, LiVolsi V . Practice Paradigms Before and After Introduction of the Diagnosis-Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): an Institutional Experience. Endocr Pathol. 2020; 31(2):174-181. DOI: 10.1007/s12022-020-09614-5. View

Brandler T, Zhou F, Liu C, Serrano A, Sun W, Nikiforov Y . Molecular Profiles of Noninvasive, Minimally Invasive, and Invasive Follicular Patterned Thyroid Neoplasms with Papillary Nuclear Features. Thyroid. 2023; 33(6):715-723. DOI: 10.1089/thy.2023.0047. View

Rossi E, Faquin W, Baloch Z, Fadda G, Thompson L, Larocca L . Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): Update and Diagnostic Considerations-a Review. Endocr Pathol. 2019; 30(2):155-162. PMC: 7477663. DOI: 10.1007/s12022-019-9574-7. View

Bae J, Jung S, Hirokawa M, Bychkov A, Miyauchi A, Lee S . High Prevalence of DICER1 Mutations and Low Frequency of Gene Fusions in Pediatric Follicular-Patterned Tumors of the Thyroid. Endocr Pathol. 2021; 32(3):336-346. DOI: 10.1007/s12022-021-09688-9. View

Chin P, Zhu C, Sajed D, Fishbein G, Yeh M, Leung A . Correlation of ThyroSeq Results with Surgical Histopathology in Cytologically Indeterminate Thyroid Nodules. Endocr Pathol. 2020; 31(4):377-384. DOI: 10.1007/s12022-020-09641-2. View

Bongiovanni M, Giovanella L, Romanelli F, Trimboli P . Cytological Diagnoses Associated with Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features According to the Bethesda System for Reporting Thyroid Cytopathology: A Systematic Review and Meta-Analysis. Thyroid. 2018; 29(2):222-228. DOI: 10.1089/thy.2018.0394. View

10.

Na H, Park S . Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: its updated diagnostic criteria, preoperative cytologic diagnoses and impact on the risk of malignancy. J Pathol Transl Med. 2022; 56(6):319-325. PMC: 9682216. DOI: 10.4132/jptm.2022.09.29. View

11.

Chen C, Hang J, Liu C, Wang Y, Lai C . Thyroid fine-needle aspiration cytology in Taiwan: a nationwide survey and literature update. J Pathol Transl Med. 2020; 54(5):361-366. PMC: 7483030. DOI: 10.4132/jptm.2020.07.17. View

12.

Alexander E, Kennedy G, Baloch Z, Cibas E, Chudova D, Diggans J . Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med. 2012; 367(8):705-15. DOI: 10.1056/NEJMoa1203208. View

13.

Patel K, Angell T, Babiarz J, Barth N, Blevins T, Duh Q . Performance of a Genomic Sequencing Classifier for the Preoperative Diagnosis of Cytologically Indeterminate Thyroid Nodules. JAMA Surg. 2018; 153(9):817-824. PMC: 6583881. DOI: 10.1001/jamasurg.2018.1153. View

14.

Nikas I, Ryu H . The application of high-throughput proteomics in cytopathology. J Pathol Transl Med. 2022; 56(6):309-318. PMC: 9682220. DOI: 10.4132/jptm.2022.08.30. View

15.

Kim S, Kim T, Kim K, Bae J, Kim J, Jung C . Highly prevalent BRAF V600E and low-frequency TERT promoter mutations underlie papillary thyroid carcinoma in Koreans. J Pathol Transl Med. 2020; 54(4):310-317. PMC: 7385264. DOI: 10.4132/jptm.2020.05.12. View

16.

Dobin A, Davis C, Schlesinger F, Drenkow J, Zaleski C, Jha S . STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2012; 29(1):15-21. PMC: 3530905. DOI: 10.1093/bioinformatics/bts635. View

17.

Robinson M, McCarthy D, Smyth G . edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2009; 26(1):139-40. PMC: 2796818. DOI: 10.1093/bioinformatics/btp616. View

18.

Howe E, Sinha R, Schlauch D, Quackenbush J . RNA-Seq analysis in MeV. Bioinformatics. 2011; 27(22):3209-10. PMC: 3208390. DOI: 10.1093/bioinformatics/btr490. View

19.

Ge S, Jung D, Yao R . ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics. 2019; 36(8):2628-2629. PMC: 7178415. DOI: 10.1093/bioinformatics/btz931. View

20.

Conceicao A, Da Silva C, Badial R, Valsechi M, Stuqui B, Goncalves J . Downregulation of OCLN and GAS1 in clear cell renal cell carcinoma. Oncol Rep. 2017; 37(3):1487-1496. DOI: 10.3892/or.2017.5414. View